SABIC ULTEM HU Resins, A Highlight At MD&M West 2024, Can Help Ease Transition From EtO Sterilization
Bergen op Zoom, The Netherlands, January 30, 2024 – SABIC, a global leader in the chemical industry, will highlight at MD&M West 2024 in Booth #3287 its versatile and durable ULTEM HU resins, which can help medical device manufacturers choose alternatives to ethylene oxide (EtO) sterilization. Demand is growing for materials compatible with other sterilization methods in anticipation of a new ruling by the U.S. Environmental Protection Agency (EPA) that may reduce EtO emissions from commercial sterilization facilities. ULTEM HU resins are stable across many popular sterilization processes, providing the potential for multiple use options. These resins can also withstand multiple sterilization cycles. Their excellent retention of strength and color can help reduce breakage and discoloration, thereby potentially extending the useful life of applications made with these materials.
“Increasingly stringent environmental regulations are challenging the medical device industry to find materials that support compliance,” said Maureen MacDonald-Stein, director, Portfolio Strategy and Marketing, SABIC’s Specialties business. “SABIC’s knowledgeable team of industry experts and our ongoing innovation help enable the proactive development of material solutions to address these types of challenges. In the case of upcoming reductions in EtO emissions, we offer specialty thermoplastics that help device makers to smoothly transition to other sterilization methods without impacting key material properties.”
At MD&M West 2024, SABIC will give a presentation on this topic, titled “How thermoplastic material selection impacts durability and sterilization of medical devices.” The talk, given by Paul Nugent, SABIC’s senior business manager, will take place on Wednesday, February 7 at 3:30 p.m. PST in Design Alley. It will cover properties and performance data for ULTEM HU resins compared to those of polyphenylsulfone (PPSU) resin before and after sterilization, and application case studies.
Providing Alternatives to EtO Sterilization
Ethylene oxide gas is a human carcinogen, and long-term exposure can lead to harmful effects. Therefore, on April 11, 2023, the EPA issued a proposal to significantly strengthen and update Clean Air Act standards for EtO emitted from commercial sterilizing facilities. The proposed rule would reduce EtO emissions by an estimated 80 percent.
According to the U.S. Food and Drug Administration (FDA), approximately 50 percent of sterile medical devices are treated with EtO, totaling about 20 billion devices each year. In view of the upcoming EPA rule, which requires changes such as reducing the amount of EtO applied in medical device sterilization, device makers may wish to use other methods.
ULTEM HU resins are compatible with a number of mainstream sterilization methods, including vaporized hydrogen peroxide (VHP) gas plasma, steam autoclave, gamma radiation, electron beam, X-ray and ultraviolet-C. Under exposure to repeated sterilization cycles, these materials retain their high strength, dimensional stability and attractive aesthetics.
Customers can choose ULTEM HU1000 resin, an unfilled polyetherimide (PEI) featuring excellent mechanical and thermal properties, or ULTEM HU1004 resin a PEI blend offering good ductility and enhanced hydrostability. These grades are biocompatible, resistant to chemicals and inherently flame retardant.
Thanks to their strength and stiffness, unreinforced ULTEM HU resins can replace metal in medical device components, where they deliver light weight, design flexibility and streamlined processing. SABIC’s glass fiber-reinforced grades, such as ULTEM HU2200 and HU2300 resins, may also be options when even higher strength is required.
SABIC’s medical-grade products are backed by its Healthcare Product Policy, which validates these materials meet global safety standards, are covered by an FDA Drug or Device Master File and are subject to formula lock and a stringent change management process.
#modernplasticsindia #indianplasticmagazine #modernplasticsaward #plasticnews #modernplasticsgermany #ginujoseph #modernplastic #plasticindia #plasticrecycling #sustainability #modernplasticsglobalnetwork #modernglobalnetwork #modernplasticsaward2023 #plasticmagazine #PlasticIndustry #modernplasticsmiddleeast #indianmagazine #innovations #modernplasticsamerica #modernplasticsbangladesh #modernplasticsasia #modernplasticsitaly









The C-CBP-WG CPP film:
Flexcure SF “Nutri” for NPH (Nutrition, Pharma and Hygiene) applications: Flexcure SF “Nutri” series represents a new generation radical mechanism designed especially for food packaging, pharma, and hygiene applications; for a wide range of substrates like paper, paper board and Met PET board, etc. suitable for 
Marine Lam Inks (water-based reverse lamination inks): Marine Lam Inks are meticulously crafted for Gravure to reverse printing applications, specifically tailored for BOPP and chemical-coated polyester films, presenting a low VOC solution aligned with the ecological demands of today’s society. These inks boast exceptional characteristics, including high strength coupled with low viscosity, 

Packaging for Savlon Hand wash powder:UFlex has recently forayed into the packaging of the Savlon Hand Wash Powder by ITC. The product specifications entail utilizing 12 PET/ 30 PE WHITE for packaging, ensuring high-quality and reliable containment of the hand wash powder. This collaboration underscores UFlex’s commitment to providing innovative and effective packaging 
Holographic Alu-Alu foil for pharma: The successful commercial launch of the product — the Holographic Alu-Alu Blister marks a substantial leap forward in raising industry benchmarks in pharmaceutical packaging solutions. The Holographic Alu-Alu Blister serves as a prominent manifestation of UFlex’s steadfast commitment to pushing the boundaries within the industry in terms of Brand Protection through covert features.The introduction of the Holographic Alu-Alu Blister has undeniably created an impact on the market. This product anticipates sustained growth as pharmaceutical companies increasingly recognize the inherent value of Anti-counterfeiting solutions. The company is resolute in their commitment to innovation, ensuring that it consistently meets and exceeds the evolving needs of its esteemed clients.